A detailed history of Vanguard Group Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,798,146 shares of CDMO stock, worth $43.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,798,146
Previous 3,665,188 3.63%
Holding current value
$43.1 Million
Previous $24.6 Million 10.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.34 - $9.28 $842,953 - $1.23 Million
132,958 Added 3.63%
3,798,146 $27.1 Million
Q1 2024

May 10, 2024

BUY
$5.86 - $8.79 $277,265 - $415,898
47,315 Added 1.31%
3,665,188 $24.6 Million
Q4 2023

Feb 14, 2024

SELL
$4.64 - $9.56 $3.75 Million - $7.74 Million
-809,149 Reduced 18.28%
3,617,873 $23.5 Million
Q3 2023

Nov 14, 2023

BUY
$9.4 - $14.04 $123,986 - $185,187
13,190 Added 0.3%
4,427,022 $41.8 Million
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $256,996 - $415,041
19,830 Added 0.45%
4,413,832 $61.7 Million
Q1 2023

May 15, 2023

BUY
$13.48 - $18.79 $602,717 - $840,138
44,712 Added 1.03%
4,394,002 $82.4 Million
Q4 2022

Feb 10, 2023

BUY
$12.61 - $18.74 $1.64 Million - $2.44 Million
130,365 Added 3.09%
4,349,290 $59.9 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $4.23 Million - $5.61 Million
275,783 Added 6.99%
4,218,925 $80.7 Million
Q2 2022

Aug 12, 2022

SELL
$11.63 - $21.55 $1.98 Million - $3.67 Million
-170,115 Reduced 4.14%
3,943,142 $60.2 Million
Q1 2022

May 13, 2022

BUY
$16.63 - $27.73 $1.71 Million - $2.84 Million
102,541 Added 2.56%
4,113,257 $83.8 Million
Q4 2021

Feb 14, 2022

BUY
$20.7 - $34.18 $17.2 Million - $28.4 Million
830,378 Added 26.11%
4,010,716 $117 Million
Q3 2021

Nov 12, 2021

BUY
$19.05 - $28.32 $856,392 - $1.27 Million
44,955 Added 1.43%
3,180,338 $68.6 Million
Q2 2021

Aug 13, 2021

BUY
$18.93 - $25.65 $59.4 Million - $80.4 Million
3,135,383 New
3,135,383 $80.4 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $705M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.